Ethnic differences likely lead to differing incidences age of 30); of these, 620 (39%) had type 1, and 958 (61%) had of diabetes as well as differing incidences of the accompatype 2 diabetes. The incidence of nephropathy was analyzed nying vascular complications [3, 10, 12, 14] . Type 2 diabein the patients according to postpubertal duration and year of diagnosis. tes is not rare in the young Japanese population [15, 16] .
Results. The cumulative incidence of nephropathy after 30 We have recently reported that Japanese patients with years of postpubertal diabetes was significantly higher (P Ͻ early-onset type 2 diabetes can develop severe diabetic 0.0001) in type 2 diabetic patients (44.4%, 95% CI, 37.0 to vascular complications, such as blindness or ESRF, when 51 .8%) than in type 1 diabetic patients (20.2%, 95% CI, 14.9 to 25.8%). The incidence of nephropathy among type 1 diabetic in their thirties [17] . On the other hand, a recent report patients has declined during the past two decades, whereas it in young Swedish patients with type 1 diabetes indicated has not among type 2 diabetic patients. The rate ratio for type a declining incidence of diabetic nephropathy [18] , al- 
METHODS
diabetes type, serum C-peptide levels were measured in patients treated with insulin using a synthetic human CStudy population peptide kit (C-PEPTIDE RIA; Shionogi, Tokyo, Japan). We performed a clinic-based epidemiologic observa-
The limit of detection of the kit was 0.1 ng/mL, and tional study. Patients can visit the outpatient clinic at the interassay and intra-assay coefficients of variation were Diabetes Center, Tokyo Women's Medical University, 6.4 and 6.7%, respectively. without any referrals, and the charge for treatment paid
The patients visited the clinic every one to three by the patient is the same as in the other hospitals. A months (8 visits per annum on the average). Blood preslarge population of diabetic patients (N ϭ 17,256) who sure was measured using a sphygmomanometer and an resided in the Tokyo metropolitan area (about 5400 km 2 ) appropriately sized cuff with the patient in a seated posiattended the outpatient clinic between 1965 and 1990, tion. Glycosylated hemoglobin (HbA1c) was measured which corresponds to approximately 10% of diabetic by high-performance liquid chromatography (HPLC; patients attending to a medical clinic in the metropolitan HA8110; Kyoto Daiichi Kagaku, Kyoto, Japan). The area. Among them, 1638 (9.4%) had early-onset diabetes normal range of HbA1c by HPLC was 4.8 to 6.4%. An (diagnosed before the age of 30; Fig. 1 ). Thirty-two earlyaverage of the HbA1c values during a year at first visit onset diabetic patients were excluded because they were was calculated. For the patient who had no data on prepubertal (younger than 10 years old) at examination.
HbA1c at the first visit (before 1980, HbA1c measureEight patients were excluded because of coexisting nonment had not been instituted), the average of the first diabetic renal disease, and 20 patients were excluded available year for HbA1c was used. Patient profiles rebecause they already had nephropathy before their visits garding the diagnosis of diabetes and medical treatment to our clinic. Of the remaining 1578 (9.1%) patients with to control the blood glucose level were compiled from early-onset diabetes, 620 (39%) with type 1 and 958 information obtained through interviews and data ob-(61%) with type 2 diabetes were included in the study.
tained from other hospitals attended by the patients. The proportion of male sex in each type was consistent Data on the history of diabetes (any type of diabetes) with previous reports in a young Japanese diabetic popuin first-degree relatives were obtained from patients by lation [16, 17, 28] .
interview. The diagnosis of diabetes and classification of diabetes type (type 1 or type 2) was made according to the World Outcome measures Health Organization criteria [29] . Briefly, type 1 diabetes In accordance with suggestions by Parving et al, diawas defined as the patient being prone to ketosis and betic nephropathy was diagnosed clinically if the followrequiring insulin therapy within one year after the diaging criteria were fulfilled: persistent proteinuria, presnosis. Type 2 diabetes was diagnosed if the patient was ence of diabetic retinopathy, and absence of clinical or found not to be ketosis prone, did not require insulin laboratory evidence of disease other than diabetic netherapy for more than one year after the diagnosis, phropathy in the kidneys or renal tract [30] . Proteinuria and/or exhibited preserved insulin secretion even when was measured at each visit (every 1 to 3 months) using treated with insulin. Type 2 diabetes was diagnosed beAlbustix (Miles-Sankyo, Tokyo, Japan), which has a decause of symptoms (27%), other complaints (28%), or screening tests (45%). To confirm the diagnosis of the tection limit of 300 mg/L. The onset of proteinuria was diabetes before the age of 10 years were entered into the calculation of postpubertal diabetes when they reached age 10. For patients who developed nephropathy, the contribution of person-years was accumulated personal computer using SPSS for Windows, version 6.0, until the year of onset of nephropathy. Those who reand SAS for Windows, version 6.11. mained free from nephropathy or those who deceased without developing nephropathy contributed to personyears until the last examination (the end of follow-up RESULTS up to March 1997). Those who had no nephropathy and Clinical features of patients with type 1 and type 2 discontinued visits, presumably because they went outdiabetes diagnosed before the age of 30 side of the Tokyo area, contributed to person-years until Clinical and biochemical characteristics of the patients the last clinic visit. Differences between relevant groups with early onset diabetes are shown in Table 1 . Thirtywere tested using the Student's unpaired t-test for continnine percent of the type 1 diabetic patients and 55% of uous variables and the chi-squared test for dichotomized the type 2 diabetic patients were male. The distribution variables. P values under 5% (two-tailed) were taken to indicate statistical significance. Analyses were run on a of patients according to the calendar year at diagnosis Calculated as the incidence density of diabetic nephropathy in type 2 diabetic patients divided by the incidence density in type 1 diabetic patients during the same period diagnosis, age at first visit, age at final examination, and postpubertal duration of diabetes were comparable between the type 1 and type 2 diabetic patients. Body mass index and blood pressure levels were higher, and glycosylated hemoglobin (HbA1c) levels were lower in patients with type 2 diabetes than in those with type 1 diabetes. Thirty-six percent of the type 2 diabetic patients were treated with insulin. However, their serum C-peptide levels were apparently preserved as compared with the levels in the type 1 diabetic patients. The proportion of patients who visited with referrals was similar for the type 1 and type 2 diabetic patients (71%, 95% CI, 67 to 75% vs. 66%, 95% CI, 62 to 69%). The proportion of patients with a family history of diabetes in first-degree and 56% (95% CI, 53 to 59%) in the type 2 diabetic 2 (᭹) diabetes diagnosed before the age of 30. Patients with type 2 diabetes had a significantly higher incidence of nephropathy than those patients.
with type 1 diabetes (P Ͻ 0.0001).
End points of the observation
For a total of 9357 person-years in type 1 diabetes, end points of the observation were development of diabetic was similar for the type 1 and type 2 diabetic patients.
nephropathy for 55 patients (791 person-years), the end The distribution of patients according to the age at diagof follow-up without nephropathy for 447 patients (7403 nosis of diabetes differed for the type 1 and type 2 diaperson-years), death without nephropathy for 12 patients betic patients. However, for three subgroups based on (173 person-years), and discontinued visits for 106 pathe decade in which diabetes was diagnosed (that is, at ages 0 to 9, 10 to 19, and 20 to 29 years), the age at tients (990 person-years). For a total of 10,917 person- Calculated as the incidence density of diabetic nephropathy in type 2 diabetic patients divided by the incidence density in type 1 diabetic patients Calculated as the incidence density of diabetic nephropathy in each group (that is, calendar year at diagnosis of diabetes between 1970 and 1974, 1975 and 1979, and 1980 and 1984) divided by the incidence density of patients with diabetes diagnosed between 1965 and 1969 as reference c Calculated as the incidence density of diabetic nephropathy in type 2 diabetic patients divided by the incidence density in type 1 diabetes years in type 2 diabetes, end points of the observation tically significant and persistently high incidence of nephropathy in patients with type 2 compared with those were development of diabetic nephropathy for 143 patients (1867 person-years), the end of follow-up without with type 1 diabetes. The rate ratio for type 2 diabetic patients relative to type 1 diabetic patients was 2.04 (95% nephropathy for 403 patients (6464 person-years), death without nephropathy for 3 patients (44 person-years), CI, 1.50 to 2.78). The cumulative incidence of nephropathy after 30 and discontinued visits for 409 patients (2542 personyears).
years of postpubertal diabetes was significantly higher (P Ͻ 0.0001) for patients with type 2 diabetes (44.4%, Incidence density of diabetic nephropathy in type 1 95% CI, 37.0 to 51.8%) than for those with type 1 diabeand type 2 diabetes tes (20.2%, 95% CI, 14.9 to 25.8%; Fig. 2 ). Provided that the type 2 diabetic patients who discontinued their clinic The incidence density of diabetic nephropathy was visits without nephropathy had no nephropathy until the calculated for five-year periods on the basis of both the final date of this study (March 1997), it still would have entire duration of diabetes and the postpubertal duration of diabetes (Table 2) . Both calculations revealed a statisremained significantly higher (P Ͻ 0.0001) for the pa- CI denotes confidence interval. Covariates considered were sex, age at diagnosis of diabetes, calendar year at diagnosis of diabetes, observation year (postpubertal duration of diabetes). The quadratic term of observation year was necessary to get an adequate fit to data. The effect of calendar year was significant only for type 1 diabetic patients. The final model included only the linear term of observation year, the quadratic term of observation year and the calendar year of diagnosis as significant covariates. tients with type 2 diabetes (32.9%, 95% CI, 27.3 to whereas the incidence among the patients with type 2 diabetes remained persistently high. Patients who devel-38.5%) than for those with type 1 diabetes. The cumulative incidences were similar for males and females in oped type 1 diabetes between 1980 and 1984 had a significantly lower incidence (3.63 out of 1000 person-years) both types. The cumulative incidences were also similar between those who visited with and without referrals than those who developed type 1 diabetes between 1965 and 1969 (10.62 out of 1000 person-years, rate ratio 0.34, and between those with and without a family history of diabetes, in both types. P ϭ 0.002). The rate ratio for patients with type 2 diabetes diagnosed between 1965 and 1969 relative to that for Analysis of the incidence of diabetic nephropathy in three groups according to the age at diagnosis of diabetes patients with type 1 diabetes diagnosed in the same period was 1.17 (95% CI, 0.61 to 2.25; Table 4 ). The rate revealed a consistently higher incidence of nephropathy in the patients with type 2 diabetes than in the patients ratio for the type 2 diabetic patients relative to the type 1 diabetic patients increased during the past two decades, with type 1 diabetes ( Table 3) .
The effect of the calendar year at diagnosis on the being 2.74 (95% CI, 1.17 to 6.41) in the patients with type 2 diabetes diagnosed between 1980 and 1984 relative to incidence of nephropathy is shown in Tables 4 and 5. The incidence of nephropathy among the patients with the patients with type 1 diabetes diagnosed in the same period. type 1 diabetes declined during the past two decades, Figure 3 showed the cumulative incidence of nephropperson-years for type 1 diabetes were used for model fitting. The final models included only the linear term athy in patients with early-onset type 1 (Fig. 3A) and type 2 (Fig. 3B) diabetes, according to the year of diagnoof the observation year, the quadratic term of the observation year, and the calendar year of diagnosis as signifisis. The cumulative incidence was significantly lower in patients with type 1 diabetes diagnosed between 1975 cant factors, which corresponded to the results of crude analyses. The quadratic term was necessary to get an and 1979 and between 1980 and 1984, than in those with type 1 diabetes diagnosed between 1965 and 1969.
adequate fit. The effect of calendar year was significant for only type 1 diabetic patients and was included as a For simultaneously analyzing the effect of multiple factors, multivariate Poisson log-linear models were fitlinear term. Models were fitted to type 1 and type 2 diabetes separately because parameters were entirely ted to the data. As covariates, sex, age at diagnosis of diabetes, calendar year of diagnosis, and observation different. Predicted cumulative incidences were calculated based on fitted models, and confidence intervals year (postpubertal duration of diabetes) were considered. Simple models that allowed an interpretation conwere calculated using asymptomatic variance matrices of the estimated parameters. sistent with that of a crude analysis could not be obtained if we included patients who were diagnosed before age
The estimated cumulative incidence from the Poisson regression models after 20 years of postpubertal diabetes 10 because of the complicated interaction among age at diagnosis, year of diagnosis, and observation year. We declined from 34.2% (95% CI, 20.9 to 53.7%) in the patients with type 1 diabetes diagnosed between 1965 therefore deleted those patients and used the observation after 20 years for increasing the reliability of predicand 1969 to 12.3% (95% CI, 6.5 to 23.1%) in those with type 1 diabetes diagnosed between 1980 and 1984, tion based on the models. In all, 128 events in 10,791 person-years for type 2 diabetes and 44 events in 6288 whereas it remained unchanged among the patients with type 2 diabetes and was 35.9% (95% CI, 28.1 to 45.3%; cause of the lower frequencies of symptoms early in the disease. A lack of awareness of diabetes and its Table 5 ).
complications is unique to type 2 diabetes and could be Risk analysis for diabetic nephropathy in type 1 and responsible for such patients developing diabetic netype 2 diabetes phropathy and ESRF [17, 22, 42] . Interestingly, the incidence density of diabetic nephropathy in our patient In both type 1 and type 2 diabetes, patients who developed nephropathy showed significantly higher levels of population declined after 15 to 20 years of diabetes duration in both types of diabetes. The finding has been HbA1c and blood pressure than those who did not (Table 6). The incidence of nephropathy increased with inconfirmed in type 1, but not in type 2 diabetes. Clinical features such as sex and age at diagnosis of creasing HbA1c values and blood pressure levels in both types of diabetes (Fig. 4) . The incidence of nephropathy diabetes were different between the two types. The differences are not due to a selection bias, as other reports was higher in patients with type 2 diabetes than those with type 1 diabetes at every stratum of HbA1c. Patients include more female Japanese patients with type 1 diabetes [28] , and patients with type 2 diabetes were older at with type 1 diabetes and the highest blood pressure levels showed a significantly higher incidence of nephropathy diagnosis than those with type 1 diabetes in a population with early-onset diabetes [16] . The high incidence of than those with type 2 diabetes and the same blood pressure value (P Յ 0.05).
nephropathy for patients with type 2 diabetes shown in our study is unlikely to be affected by these different features, since the analysis according to the sex and age DISCUSSION at diagnosis of diabetes showed the same results (Table  This study did not aim at investigating the effects of 3). True duration of diabetes may be longer than the putative risks (such as glycemic control, blood pressure, known duration in type 2 diabetes, but the difference or lipid profiles on the development of diabetic nephropbetween the two in the present study is presumed to be athy), but aimed at determining associations of the type less than a few years because type 2 diabetes rarely of diabetes and year of diagnosis with the incidence of occurs before the age of 15. Provided that patients with nephropathy under the conditions that: (1) both type 1 type 2 diabetes had a period of few years of diabetes and type 2 diabetes occur in the young homogeneous before the diagnosis, it could not have accounted for the population in Japan; (2) direct comparison was made significant high incidence of nephropathy in patients with within the same unit between type 1 and type 2 diabetes; type 2 compared with those with type 1 diabetes. (3) type of diabetes was carefully defined; (4) referral Ethnicity profoundly affects the incidence of diabetes bias was evaluated; and (5) alternative causes of proteinas well as its vascular complications. The results of the uria were excluded. The study showed the incidence of present study showed that type 2 diabetes occurred as nephropathy to be twice as high in the patients with type early as the teens in our Japanese population, and that 2 as in the patients with type 1 in early-onset diabetes.
the incidence of diabetic nephropathy in early-onset type The incidence of nephropathy was not influenced by 2 diabetic patients was extraordinarily higher than that gender, referral, and existence of diabetes in first-degree in type 1 diabetic patients in Japan. The high incidence relatives. While the incidence of type 1 diabetes has of diabetic nephropathy in type 2 diabetic patients comdecreased in our patient population during the past two pared with type 1 diabetic patients in this study is consisdecades, type 2 diabetes has remained persistently high.
tent with the findings of Cowie et al [3] . They demonConsequently, the rate ratio for the incidence of nestrated a high and increasing incidence of diabetic ESRF phropathy in type 2 diabetic patients relative to type 1 among black patients with type 2 diabetes as compared diabetic patients has become more prominent in those with black patients with type 1 diabetes, although they young, recently diagnosed diabetic patients in Japan. The neither investigated the onset of diabetic nephropathy increasing rate ratio for the incidence of nephropathy in nor included patients with type 1 and type 2 diabetes of type 2 diabetic patients relative to type 1 diabetic patients a comparable age. That study clearly revealed an ethnic suggests that we will see a further increase in ESRF in difference between whites and blacks for the incidence patients with type 2 diabetes in the future. This situation of diabetic ESRF, particularly in type 2 diabetes. Ethcalls for urgent, intense educational efforts in the medical nicity may be one reason for the high incidence of diacommunity and the general population. Such efforts betic nephropathy among Japanese patients with earlycould save lives and lead to considerable economic savonset type 2 diabetes. While it appears that the incidence ings, not only in type 1 [41] but also in type 2 diabetes.
of diabetic nephropathy in patients with type 2 diabetes The increased incidence of diabetic nephropathy in varies markedly according to ethnicity, this is not necestype 2 diabetic patients was found within 10 years after sarily the case for type 1 diabetes. the diagnosis of diabetes. This may be explained by the Our study demonstrates that the incidence of diabetic nephropathy in Japanese patients with type 1 diabetes systematic delay in the diagnosis of type 2 diabetes be-has decreased with the increasing calendar year at diaghigher (P Ͻ 0.0001) for the patients with type 2 diabetes than for those with type 1 diabetes (data not shown). nosis of diabetes. This confirms the finding reported by Bojestig et al that the cumulative incidence of nephropaThis suggests that type 2 diabetes is the major cause of nephropathy in early-onset diabetes in Japan. thy in type 1 diabetes has decreased substantially during the past two decades [18] . We were unable to clarify the
In conclusion, the present study demonstrates significant differences in the incidence of diabetic nephropathy reason for the declining incidence of nephropathy in this study; however, it is speculated that metabolic regulation according to the type of diabetes and the year of diagnosis in early-onset diabetes in Japan. Such an analysis, and systemic blood pressure control, both of which evidently affected the development of nephropathy (Table  particularly in the non-Caucasian population, is awaited. Diabetic nephropathy and progression to ESRF in type 6 and Fig. 4) , have been improved in recent years and thus reduced the incidence in patients with type 1 diabe-2 diabetes should be preventable through metabolic control [45-47], control of blood pressure [26, 48] , use of tes. The effects of these two factors on inhibiting nephropathy have been supported by prospective and/or angiotensin-converting enzyme inhibitors [26, 49, 50] , protein restriction [51] , and discontinuation of smoking observational studies both in type 1 and type 2 diabetes [26] . The increasing prevalence of type 2 diabetes [52] [27, [43] [44] [45] [46] [47] [48] [49] [50] [51] . For patients with type 1 diabetes, regular and of ESRF in type 2 diabetic patients worldwide [3, clinic visits are mandatory, which may induce better met-8-12, 21-25] urgently demands programs for prevention of abolic and blood pressure control; thus, this may have diabetic nephropathy, especially in a high-risk population. caused a cumulative decline in the incidence of nephropathy with increasing calendar year at diagnosis of diabe-ACKNOWLEDGMENTS tes. However, this is unlikely the case for type 2 diabetic patients, presumably because their disease is not neces- ing these risk factors between the two types of diabetes,
